OpenLB
Open Library of Bioscience
Advanced Search
Frontiers in pharmacology
2021;12 783108.

Antimicrobial and Anti-inflammatory Effects of a Novel Peptide From the Skin of Frog .

Maolin Tian, Junfang Liu, Jinwei Chai, Jiena Wu, Xueqing Xu
Author Information
  1. Maolin Tian: Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  2. Junfang Liu: Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  3. Jinwei Chai: Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  4. Jiena Wu: Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  5. Xueqing Xu: Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
PMID: 34975482 DOI: 10.3389/fphar.2021.783108

Abstract

Brevinins are an important antimicrobial peptide (AMP) family identified in the skin of frogs and generally contain a characteristic ranabox structure at their C-terminal sequence. Herein a novel AMP named brevinin-2MP has been identified from the skin of the frog by molecular cloning. Brevinin-2MP (GVITDTLKGVAKTVAAELLRKAHCKLTNSC) with a high amphipathic α-helix in sodium dodecyl sulfate solutions can destroy bacterial cell membrane and kill microbes. Furthermore, brevinin-2MP has been found to inhibit the lipopolysaccharide (LPS)-induced expression of pro-inflammatory NO, MCP-1, IL-6, and TNF-α binding unidentified targets on the cell membrane and consequently suppressing the activation of MAPK/NF-κB signaling cascades induced by LPS in RAW 264.7 cells. Consistently, brevinin-2MP significantly alleviates the acute inflammatory response in carrageenan-induced mice paw. In conclusion, brevinin-2MP with anti-inflammatory and antimicrobial properties will be an ideal candidate drug molecule for bacterial inflammation treatment.

Keywords

LPS Microhyla pulchra amphibian anti-inflammation antimicrobial peptide brevinin-2

References

  1. Adv Exp Med Biol. 2014;818:197-212 [PMID: 25001538]
  2. Antibiotics (Basel). 2020 Feb 14;9(2): [PMID: 32075067]
  3. Curr Protein Pept Sci. 2017;18(12):1263-1272 [PMID: 28699512]
  4. Trends Biotechnol. 2011 Sep;29(9):464-72 [PMID: 21680034]
  5. Front Pharmacol. 2021 Aug 16;12:731056 [PMID: 34483941]
  6. J Med Chem. 2018 Dec 13;61(23):10709-10723 [PMID: 30427189]
  7. Peptides. 2006 Dec;27(12):3077-84 [PMID: 16979798]
  8. J Biol Chem. 2021 Jan-Jun;296:100670 [PMID: 33864815]
  9. Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1496-1503 [PMID: 31896580]
  10. Infect Immun. 1996 Dec;64(12):4922-7 [PMID: 8945527]
  11. Cell. 2006 Feb 24;124(4):783-801 [PMID: 16497588]
  12. Chem Rev. 2015 Feb 25;115(4):1760-846 [PMID: 25594509]
  13. Cell Mol Life Sci. 2015 Feb;72(3):557-581 [PMID: 25332099]
  14. Biomed Pharmacother. 2020 Mar;123:109753 [PMID: 31865148]
  15. Biosci Biotechnol Biochem. 2020 Jan;84(1):143-153 [PMID: 31549575]
  16. Trends Pharmacol Sci. 2019 Jul;40(7):517-528 [PMID: 31230616]
  17. Peptides. 2012 Apr;34(2):275-82 [PMID: 22374306]
  18. Comp Biochem Physiol Part D Genomics Proteomics. 2014 Mar;9:49-57 [PMID: 24463457]
  19. Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-9 [PMID: 16413829]
  20. Toxicon. 2007 Nov;50(6):746-56 [PMID: 17688900]
  21. Biochim Biophys Acta. 2004 Jan 14;1696(1):1-14 [PMID: 14726199]
  22. Toxicon. 2008 Sep 1;52(3):465-73 [PMID: 18621071]
  23. Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-90 [PMID: 1449472]
  24. Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406 [PMID: 17158938]
  25. Peptides. 2003 Nov;24(11):1681-91 [PMID: 15019199]
  26. Int J Mol Sci. 2012;13(3):3229-44 [PMID: 22489150]
  27. Antimicrob Agents Chemother. 2005 May;49(5):1727-32 [PMID: 15855488]
  28. Elife. 2021 Apr 20;10: [PMID: 33875135]
  29. Regul Pept. 2008 Nov 29;151(1-3):153-9 [PMID: 18501981]
  30. Crit Rev Immunol. 2011;31(5):379-446 [PMID: 22142165]
  31. Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54 [PMID: 7999137]
  32. Chem Biol Drug Des. 2009 Nov;74(5):488-93 [PMID: 19793185]
  33. FEBS Lett. 2001 Oct 19;507(1):95-100 [PMID: 11682065]
  34. Acta Biochim Biophys Sin (Shanghai). 2017 May 1;49(5):450-457 [PMID: 28338958]
  35. FEMS Microbiol Rev. 2016 Jul;40(4):480-93 [PMID: 27075488]
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0brevinin-2MPantimicrobialLPSpeptideAMPidentifiedskinbacterialcellmembraneBrevininsimportantfamilyfrogsgenerallycontaincharacteristicranaboxstructureC-terminalsequenceHereinnovelnamedfrogmolecularcloningBrevinin-2MPGVITDTLKGVAKTVAAELLRKAHCKLTNSChighamphipathicα-helixsodiumdodecylsulfatesolutionscandestroykillmicrobesFurthermorefoundinhibitlipopolysaccharide-inducedexpressionpro-inflammatoryNOMCP-1IL-6TNF-αbindingunidentifiedtargetsconsequentlysuppressingactivationMAPK/NF-κBsignalingcascadesinducedRAW2647cellsConsistentlysignificantlyalleviatesacuteinflammatoryresponsecarrageenan-inducedmicepawconclusionanti-inflammatorypropertieswillidealcandidatedrugmoleculeinflammationtreatmentAntimicrobialAnti-inflammatoryEffectsNovelPeptideSkinFrogMicrohylapulchraamphibiananti-inflammationbrevinin-2

Similar Articles

Cited By